This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

. 2020 Mar 24.

doi: 10.1001/jama.2020.4742. Online ahead of print.

Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics

Andre C Kalil¹

Affiliations

PMID: 32208486
DOI: 10.1001/jama.2020.4742

Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics

Andre C Kalil. JAMA. 2020.

. 2020 Mar 24.

doi: 10.1001/jama.2020.4742. Online ahead of print.

Author

Andre C Kalil¹

Affiliation

¹ Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska.

PMID: 32208486
DOI: 10.1001/jama.2020.4742

Similar articles

Current regulatory approaches for accessing potential COVID-19 therapies.
Halimi V, Daci A, Stojanovska S, Panovska-Stavridis I, Stevanovic M, Filipce V, Grozdanova A. Halimi V, et al. Version 2. J Pharm Policy Pract. 2020 May 16;13:16. doi: 10.1186/s40545-020-00222-6. eCollection 2020. J Pharm Policy Pract. 2020. PMID: 32454981 Free PMC article.
Off-label use of anti-cancer drugs between clinical practice and research: the Italian experience.
Lerose R, Musto P, Aieta M, Papa C, Tartarone A. Lerose R, et al. Eur J Clin Pharmacol. 2012 May;68(5):505-12. doi: 10.1007/s00228-011-1173-6. Epub 2011 Dec 14. Eur J Clin Pharmacol. 2012. PMID: 22166932 Review.
Balancing risk in ophthalmic prescribing: assessing the safety of anti-VEGF therapies and the risks associated with unlicensed medicines.
Kaiser PK, Cruess AF, Bogaert P, Khunti K, Kelly SP. Kaiser PK, et al. Graefes Arch Clin Exp Ophthalmol. 2012 Nov;250(11):1563-71. doi: 10.1007/s00417-012-2123-4. Epub 2012 Aug 12. Graefes Arch Clin Exp Ophthalmol. 2012. PMID: 23011000 Free PMC article. Review.
[Compassionate use of off-label drugs: need for a change in Spain].
Avendaño Solá C. Avendaño Solá C. Med Clin (Barc). 2009 Sep 26;133(11):425-6. doi: 10.1016/j.medcli.2009.07.003. Epub 2009 Sep 18. Med Clin (Barc). 2009. PMID: 19766261 Spanish. No abstract available.
[COVID-19. The only certainty is the uncertainty].
Briem H. Briem H. Laeknabladid. 2020 Mars;106(3):119. doi: 10.17992/lbl.2020.03.469. Laeknabladid. 2020. PMID: 32124733 Icelandic. No abstract available.

See all similar articles

Cited by 12 articles

Prior and novel coronaviruses, Coronavirus Disease 2019 (COVID-19), and human reproduction: what is known?
Segars J, Katler Q, McQueen DB, Kotlyar A, Glenn T, Knight Z, Feinberg EC, Taylor HS, Toner JP, Kawwass JF; American Society for Reproductive Medicine Coronavirus/COVID-19 Task Force. Segars J, et al. Fertil Steril. 2020 Jun;113(6):1140-1149. doi: 10.1016/j.fertnstert.2020.04.025. Epub 2020 Apr 16. Fertil Steril. 2020. PMID: 32482250 Free PMC article.
Current regulatory approaches for accessing potential COVID-19 therapies.
Halimi V, Daci A, Stojanovska S, Panovska-Stavridis I, Stevanovic M, Filipce V, Grozdanova A. Halimi V, et al. Version 2. J Pharm Policy Pract. 2020 May 16;13:16. doi: 10.1186/s40545-020-00222-6. eCollection 2020. J Pharm Policy Pract. 2020. PMID: 32454981 Free PMC article.
SARS-CoV-2/COVID-19: Evidence-Based Recommendations on Diagnosis and Therapy.
Bein B, Bachmann M, Huggett S, Wegermann P. Bein B, et al. Geburtshilfe Frauenheilkd. 2020 May;80(5):491-498. doi: 10.1055/a-1156-3991. Epub 2020 May 18. Geburtshilfe Frauenheilkd. 2020. PMID: 32435065 Free PMC article.
Natural experiment concept to accelerate the Re-purposing of existing therapeutics for Covid-19.
Daughton CG. Daughton CG. Glob Epidemiol. 2020 May 15;2:100026. doi: 10.1016/j.gloepi.2020.100026. Online ahead of print. Glob Epidemiol. 2020. PMID: 32427166 Free PMC article.
A review of the safety of favipiravir - a potential treatment in the COVID-19 pandemic?
Pilkington V, Pepperrell T, Hill A. Pilkington V, et al. J Virus Erad. 2020 Apr 30;6(2):45-51. J Virus Erad. 2020. PMID: 32405421 Free PMC article.

See all "Cited by" articles

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Medical
- ClinicalTrials.gov